EVLV
Evolv Technologies Holdings, Inc.6.86
+0.10+1.48%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
1.20BP/E (TTM)
-Basic EPS (TTM)
-0.35Dividend Yield
0%Recent Filings
8-K
Q4 profit, raised 2026 guide
Evolv Technologies posted Q4 revenue of $38.5M, up 32% YoY, with $120.5M ending ARR up 21% and rare Q4 net income of $10.9M. Full-year revenue hit $145.9M, up 40%, flipping to positive operating cash flow of $18.7M while boosting cash to $69.0M. Raised 2026 revenue guide to $172-178M. ARR growth outpaces revenue.
10-K
FY2025 results
Evolv Technologies drove FY2025 revenue to $145.9M, up 40% y/y, with subscription revenue surging 29% to $83.8M from expanded deployments under pure subscription model. Q4 momentum accelerated as product revenue tripled y/y to $21.6M, fueled by purchase subscriptions including a major Georgia education deal, though margins compressed to -12% from higher eXpedite launch costs. Operating loss narrowed 41% to $48.5M via 25% sales/marketing cuts post-reductions; Adjusted EBITDA flipped positive at $11.1M. $69M liquidity supports $30M drawn debt; ARR hit $120.5M, up 21%. Supply disruptions risk quarterly deployments.
8-K
New director replaces resigning board member
Evolv Technologies accepted Bilal Zuberi's resignation from its Board on February 10, 2026, to pursue other endeavors, with no disagreements noted. The Board appointed Henrik Kühl, 46, as independent Class III director and Audit Committee member effective February 12, 2026. Kühl brings 25+ years in strategy, M&A, and capital allocation from Axon. His expertise bolsters growth execution.
8-K
Q3 revenue jumps 57%
Evolv Technologies posted Q3 revenue of $42.9 million, up 57% year-over-year, fueled by new customers and expansions yet padded by $7.5 million in one-offs like a record order and phasing IP fees. ARR hit $117.2 million, up 25%, with Adjusted EBITDA swinging to $5.1 million. Raised 2025 revenue guide to $142-$145 million. Profitability advances, but non-recurring boosts fade.
10-Q
Q3 FY2025 results
Evolv Technologies filed its 10-Q for Q3 ended September 30, 2025, but the document provides only header details without financial statements or MD&A. No revenue, profitability, EPS, cash flow, debt, or segment figures appear in the provided filing. Non-GAAP metrics not disclosed in the 10-Q. No M&A, impairments, or regulation specifics given. Cash position unavailable. Competition remains a key risk from Risk Factors.
IPO
Website
Employees
Sector
Industry
BBAI
BigBear.ai, Inc.
5.86-0.11
BKYI
BIO-key International, Inc.
0.66-0.01
DTII
Defense Technologies Internatio
0.01+0.00
EVEX
Eve Holding, Inc.
4.69+0.02
EVH
Evolent Health, Inc
4.07-0.05
IVDA
Iveda Solutions, Inc.
0.97+0.07
LDDFF
Liberty Defense Holdings Ltd.
0.17+0.00
SUGP
SU Group Holdings Limited
5.95-0.10
WRAP
Wrap Technologies, Inc.
2.19-0.15
XTRAF
XTRACT ONE TECHNOLOGIES INC.
0.46-0.02